In this thirteenth episode, Tom Stubbs, Co-Founder/CEO of Chronomics starts with introducing epigenetics. He describes the technology and expertise that he's brought together to create the only company in the world advancing the forefront of epigenetic biomarkers. He explains how their A.I. based health biomarker engine will be used to reduce your risk of future illness.
Lee: Hey, welcome Tom. Tom: Hey, Lee. Thank you for having me on the show. Pleasure to be here and looking forward to chatting with you. Lee: What’s the focus of Chronomics? Tom: We are very much focused on measuring health so people can avoid disease. Lee: Measuring health so that people can avoid disease, that sounds a little bit... Read MoreEpigenetic Health Monitoring to Reduce Your Future Illness Risk – EP13: Tom Stubbs (Chronomics)
In this twelfth episode, Jeff Kaditz, Founder/CEO of Q Bio begins with coronavirus chat. He goes on to explain that most medical knowledge today is probably incorrect or heavily biased. That there’s almost nothing a doctor does that couldn’t have been done 200 years ago in terms of the information. He presents his vision to run ‘search engines for the body’ and turn healthcare into hard science.
Lee: Hello and welcome to the Quantified Health, Wellness and Aging Podcast. Today we have our twelfth guest Jeff Kaditz, the CEO of Q Bio. Welcome, Jeff. Jeff: Hi, Lee. How are you doing? Lee: Well, do you have 20 minutes? This is meant to be a one in a 100 year event taking place at the moment. I don’t... Read MoreMultiscale Digital Models of Human Biology, Turning Health into a Hard Science – EP12: Jeff Kaditz (Q Bio)
In this seventh episode, Nathan Price, Professor & Associate Director of the Institute for Systems Biology, explains the concept and aspiration of 'scientific wellness'. He predicts that it will become the dominant paradigm of 21st century healthcare. He explains ‘personal, dense, dynamic data clouds’ will enable both peak wellness and disease avoidance. Possibilities that China may leapfrog the United States.
Lee: Hello, Nathan. Welcome to the seventh episode of the Hyper Wellbeing podcast. Nathan: Lee, it’s great to be with you. Lee: Appreciate it. The last time I saw you was at Hyper Wellbeing 2016 where you gave a keynote. That was greatly appreciated. Nathan: It was a great meeting. Thanks for organizing. Lee: Nathan, can you do a favor... Read More‘Scientific Wellness’ as Dominant Paradigm of 21st Century Healthcare – EP07: Nathan Price (ISB)
In this fifth episode, Don Brown, CEO LifeOmic, explains the nomenclature shift from precision medicine to precision health, details the firm footing his company has in precision health, how it’s now extending another foot forwards into hyper wellbeing. Lots of app, lifestyle medicine, lifespan, healthspan and biological age quantification chat.
Lee: Hi, so you’re CEO of LifeOmic, a company which I have been tracking for some time. Could you be so kind as to introduce, to give a brief introduction to LifeOmic? Don: Yeah, I started LifeOmic almost two or so years ago. I went through a combined degree in the PhD program many years ago and ended up taking... Read MorePrecision Medicine vs Precision Health vs Hyper Wellbeing – EP05: Don Brown (LifeOmic)
In this fourth episode, Ardy Arianpour, CEO of Seqster, shares why the future of your health data is a centralized view, controlled by you, pulled from wearables, genetic tests, logged nutritional intake as well as your medical records even if spread across institutions. He relates the unique need and ability to share our lifetime of health data transgenerationally.
Lee: Hello and welcome to the fourth episode of the Hyper Wellbeing podcast. On today’s show we have Ardy Arianpour. Ardy is the CEO and co-founder of Seqster. Ardy is a visionary genomics executive and serial entrepreneur in the biotech industry. Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic test as CCO of Pathway Genomics and SVP... Read MoreFuture of Owning, Storing & Sharing Your Health Data – EP04: Ardy Arianpour (Seqster)